Table 3 Molecular characteristics of pancreatic adenocarcinomas.

From: Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes

  

N, 177

%

KRAS

Wildtype

13

7.3

Mutated

164

93

TP53

Intact

38

21.5

Altered

139

78.5

CDKN2A/p16

Intact

43

24

Altered

133

75

n.a.

1

0.6

SMAD4

Intact

112

63

Altered

65

37

Back to article page